Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

Pfizer’s RSV vaccine has struggled to compete with one from GSK in a market that now also includes Moderna. Bloomberg Intelligence analyst John Murphy called the earnings report “largely ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Laura is an editor and staff writer at IFLScience. She obtained her Master's in Experimental Neuroscience from Imperial College London.

Pfizer’s contributions to animal health date back several decades, during which the company played a significant role in ...

Is the COVID-19 vaccine safe and effective for infants and young children? Here's what parents need to know about vaccinating their babies and toddlers against COVID-19.

Moderna Inc. recorded a quarterly loss as vaccine sales waned and the company had an unexpected charge for a canceled ...

Moderna's stock fell more ... of Novavax and GSK both fell around 1%. Pfizer's stock fell almost 2%, even after the company ...